CROI 2016 Program at a Glance
Program and Agenda
818 Pharmacokinetics, Safety, and Efficacy of Maraviroc in Pediatric Patients With R5 HIV Carlo Giaquinto 1 ; Muthuhadini P. Mawela 2 ; Kulkanya Chokephaibulkit 3 ; Annie Fang 4 ; Elna van der Ryst 5 ; Srinivas RaoValluri 4 ; ManoliVourvahis 4 ; Rebecca Zhang-Roper 6 ; Lynn McFadyen 7 ; Jayvant Heera 8 1 UnivofPadova,Padova, Italy; 2 SefakoMakgathoHlthScisUniv,Pretoria, SouthAfrica; 3 SirirajHosp,MahidolUniv,Bangkok,Thailand; 4 Pfizer, Inc, NewYork,NY,USA; 5 Pfizer Inc,TheRsrNetwork,Sandwich,UK; 6 GSK, StockleyPark,UK; 7 Pfizer, Inc,Sandwich,UK; 8 Pfizer, Inc,Groton,CT,USA 819 Safety of Tenofovir on Bone Mineral Density in HIV- Infected Youths: A 10-Year Study Vania Giacomet 1 ; Katia Maruca 2 ; Paola Erba 1 ; Maria Puzzovio 2 ; Pilar Nannini 3 ; Silvia Capelli 2 ; Alessandro Ambrosi 2 ; Gianvincenzo Zuccotti 4 ; Stefano Mora 2 1 LuigiSaccoHosp,UnivofMilan,Milan, Italy; 2 SanRaffaeleScientific Inst,Milan, Italy; 3 UnivofMilan,Milan, Italy; 4 OspedaleBuzzi,Univof Milan,Milan, Italy 2:45 PM-4:00 PM Getting a Handle on CNS Disease in Children and Adolescents 820 HIV Encephalopathy Despite Prolonged Viral SuppressionWith Slow Spontaneous Recovery Steve Innes ; Barbara Laughton; Ronald vanToorn; Els Dobbels; Mark F. Cotton StellenboschUnivandTygerbergChildren'sHosp,CapeTown,South Africa 821 A Diffusion Tensor Imaging and Neurocognitive Study of HIV-Infected Children Jacqueline Hoare 1 ; J.P. Fouche 1 ; Nicole Phillips 1 ; John Joska 1 ; Robert Paul 2 ; Kirsten Donald 1 ; KevinThomas 1 ; Dan Stein 1 1 UnivofCapeTown,CapeTown,SouthAfrica; 2 Missouri InstofMental Hlth,St.Louis,MO,USA 822 Brain Volumes, HIV Disease Severity, and Substance Use in Perinatally Infected Youth Paige L.Williams 1 ;Yanling Huo 1 ; Shirlene D.Wang 2 ; Kristina Uban 3 ; Kathleen Malee 4 ; Sharon L. Nichols 5 ; Russell B.Van Dyke 6 ; LeiWang 7 ; Elizabeth R. Sowell 8 ; for the Pediatric HIV/AIDS Cohort Study (PHACS) and the Pediatric Imaging, Neurocognition, and Genetics (PING) Study 1 HarvardSchofPH,Boston,MA,USA; 2 NorthwesternUniv,Chicago, IL, USA; 3 Children’sHospofLosAngeles,LosAngeles,CA,USA; 4 Annand RobertH.LurieChildren’sHospofChicago,Chicago, IL,USA; 5 Univof CaliforniaSanDiego,SanDiego,CA,USA; 6 TulaneUnivSchofMed,New Orleans,LA,USA; 7 NorthwesternUniv,FeinbergSchofMed,Chicago, IL, USA; 8 KeckSchofMedat theUnivofSouthernCalifornia,LosAngeles, CA,USA Session P-T2 Poster Abstracts Hall D
823 Long-term Effects on Basal Ganglia in YouthWith Perinatally Acquired HIV Infection Christine Paula de los Angeles 1 ; Paige L.Williams 2 ;Yanling Huo 2 ; Kathleen Malee 3 ; John G. Csernansky 1 ; RamYogev 3 ; Russell B.Van Dyke 4 ; Elizabeth R. Sowell 5 ; LeiWang 1 ; for the Pediatric HIV/AIDS Cohort Study (PHACS) 1 NorthwesternUniv,FeinbergSchofMed,Chicago, IL,USA; 2 Harvard SchofPH,Boston,MA,USA; 3 AnnandRobertH.LurieChildren’sHosp ofChicago,Chicago, IL,USA; 4 TulaneUnivSchofMed,NewOrleans,LA, USA; 5 KeckSchofMedat theUnivofSouthernCalifornia,LosAngeles, CA,USA 2:45 PM-4:00 PM Immunopathogenesis in HIV-Infected Children 824 Risk Factors for BCG IRIS in HIV-Infected infants Starting Antiretroviral Treatment Session P-T3 Poster Abstracts Varghese K. George 1 ; Elisa Nemes 2 ; AsmaToefy 2 ;Willem Hanekom 2 ; Mark F. Cotton 3 ; Charles D. Mitchell 4 ; James Oleski 5 ; Bonnie Zimmer 6 ; Terry Fenton 7 ; Savita Pahwa 4 ; for the IMPAACT P1073 1 UnivofMiami,Miami,FL,USA; 2 UnivofCapeTown,CapeTown,South Africa; 3 StellenboschUnivandTygerbergChildren’sHosp,CapeTown, SouthAfrica; 4 UnivofMiamiMillerSchofMed,Miami,FL,USA; 5 New JerseyMedSch,Newark,NJ,USA; 6 FrontierSci&TechRsrFndn, Inc, Amherst,MA,USA; 7 SDAC,HarvardSchofPH,Boston,MA,USA 825 Enhanced Inflammation and Rotavirus Vaccine Responses in Perinatal HIV-1 Infection Priyanka Uprety 1 ; Jane Lindsey 2 ; Myron Levin 3 ; Kaitlin Rainwater- Lovett 1 ; Carrie Ziemniak 1 ; Susan Kaplan 4 ; Micki Nelson 4 ; Amanda Zadzilka 5 ; AdrianaWeinberg 6 ; Deborah Persaud 1 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 HarvardSchofPH,Boston, MA,USA; 3 UnivofColoradoAnschutzMedCampus,Aurora,CO,USA; 4 MerckRsrLab,NorthWales,PA,USA; 5 FrontierSci&TechRsrFndn, Inc, Amherst,NY,USA; 6 UnivofColorado,Denver,CO,USA 826 Vitamin D Supplementation Decreases Immune Activation and Exhaustion in HIV+ Youth Allison R. Eckard 1 ; Ann Chahroudi 2 ; Julia C. Rosebush 2 ; Mary Ann O'Riordan 3 ; Julie E. Daniels 2 ; Monika Uribe-Leitz 2 ; Bruce Kinley 3 ; Danielle Labbato 3 ;VinTangpricha 2 ; Grace A. McComsey 3 1 MedUnivofSouthCarolina,Charleston,SC,USA; 2 EmoryUnivSchof Med,Atlanta,GA,USA; 3 CaseWesternReserveUniv,Cleveland,OH,USA 827 Contrasting CTL Impact in Distinct Phenotypes of Nonprogressing Pediatric HIV Ellen M. Leitman 1 ; Astrid Gall 2 ; Paul Kellam 2 ; Jacqui Brener 1 ; Azim Ansari 1 ; Christina F.Thobakgale 3 ; Philippa C. Matthews 1 ; Philip Goulder 1 1 UnivofOxford,Oxford,UK; 2 WellcomeTrustSanger Inst,Hinxton,UK; 3 HIVPathogenesisProg,DorisDukeMedRsr Inst,UnivofKwaZulu-Natal, Durban,SouthAfrica 828 Impact of HLA-B*81-driven Escape Mutation L188F on VRC in Pediatric Slow Progression Ming-HanTsai 1 ; Maximilian Muenchhoff 1 ; Emily Adland 1 ; Anna Carlqvist 1 ; David Cole 2 ; Andrew K. Sewell 2 ; Jonathan Carlson 3 ;Thumbi P. Ndungu 4 ; Philip Goulder 1 ; for the Professor Philip Goulder's Group 1 UnivofOxford,Oxford,UK; 2 CardiffUniv,Cardiff,UK; 3 MicrosoftRsr, Redmond,WA,USA; 4 UnivofKwaZulu-Natal,Durban,SouthAfrica
Hall D
Poster Listings
72
CROI 2016
Made with FlippingBook HTML5